Subject
Atherosclerosis is a monthly peer-reviewed scientific journal established in 1970 and published by Elsevier. It is the official journal of the European Atherosclerosis Society and is affiliated with the International Atherosclerosis Society. Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biologyand disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The journal can publish original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors. The editor-in-chief is Arnold von Eckardstein. According to the Journal Citation Reports, the journal has a 2021 impact factor of 6.847. Source: Wikipedia (en)
Editions published in Atherosclerosis 200
-
Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review.
-
Vascular disease in cocaine addiction
-
Dyslipidaemia in the Middle East: Current status and a call for action
-
Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease
-
Protein sorting gone wrong--VPS10P domain receptors in cardiovascular and metabolic diseases
-
The ubiquitin-activating enzyme E1 as a novel therapeutic target for the treatment of restenosis
-
Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factors
-
Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells
-
Where to now in cardiovascular disease prevention
-
Non-invasive imaging of atherosclerosis regression with magnetic resonance to guide drug development
-
Genetic analysis of atherosclerosis identifies a major susceptibility locus in the major histocompatibility complex of mice
-
Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
-
Promoter methylation of glucocorticoid receptor gene is associated with subclinical atherosclerosis: A monozygotic twin study
-
Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice
-
Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis
-
Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability
-
Liver X receptors at the intersection of lipid metabolism and atherogenesis
-
The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis
-
Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014)
-
Functional interaction between COL4A1/COL4A2 and SMAD3 risk loci for coronary artery disease
-
Common genetic variants and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA).
-
The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study
-
P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)
-
Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials
-
MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1
-
Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes--an 8-year prospective study
-
Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders
-
Beclin 1 knockdown retards re-endothelialization and exacerbates neointimal formation via a crosstalk between autophagy and apoptosis
-
Proteomic identification of differentially expressed proteins in vascular wall of patients with ruptured intracranial aneurysms
-
Interleukin-1 potently contributes to 25-hydroxycholesterol-induced synergistic cytokine production in smooth muscle cell-monocyte interactions
-
Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials.
-
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia
Subject - wd:Q4813570